Genetic characterization of plasmid-mediated fluoroquinolone efflux pump QepA among ESBL-producing Escherichia coli isolates in Mexico

Braz J Microbiol. 2023 Dec;54(4):2791-2797. doi: 10.1007/s42770-023-01115-x. Epub 2023 Sep 13.

Abstract

Antimicrobial resistance is a major global public health problem, with fluoroquinolone-resistant strains of Escherichia coli posing a significant threat. This study examines the genetic characterization of ESBL-producing E. coli isolates in Mexican hospitals, which are resistant to both cephalosporins and fluoroquinolones. A total of 23 ESBL-producing E. coli isolates were found to be positive for the qepA gene, which confers resistance to fluoroquinolones. These isolates exhibited drug resistance phenotypes and belonged to specific sequence types and phylogenetic groups. The genetic context of the qepA gene was identified in a novel genetic context flanked by IS26 sequences. Mating experiments showed the co-transfer of qepA1 and chrA determinants alongside blaCTX-M-15 genes, emphasizing the potential for these genetic structures to spread among Enterobacterales. The emergence of multidrug-resistant Gram-negative bacteria carrying these resistance genes is a significant clinical concern for public healthcare systems.

Keywords: ESBL; Efflux pump qepA; Escherichia coli; Fluoroquinolone.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Escherichia coli
  • Escherichia coli Infections* / microbiology
  • Fluoroquinolones* / pharmacology
  • Humans
  • Mexico
  • Phylogeny
  • Plasmids / genetics
  • beta-Lactamases / genetics

Substances

  • Fluoroquinolones
  • Anti-Bacterial Agents
  • beta-Lactamases